December 23, 2002
Genelabs’ Marketing Authorization Application for Lupus Drug Submitted in Europe

December 19, 2002
GENELABS TECHNOLOGIES GRANTS NON-EXCLUSIVE LICENSE FOR DNA AMPLIFICATION TECHNOLOGY

November 15, 2002
GENELABS SUBMITS PHASE III CLINICAL TRIAL PROTOCOL FOR PRESTARA(TM) IN LUPUS

November 14, 2002
GENELABS ANNOUNCES RECENT HIGHLIGHTS AND 
THIRD QUARTER 2002 FINANCIAL RESULTS

November 1, 2002
Genelabs Announces Highlights From Post-ACR Symposium in New Orleans: -Bone as a Target Organ for Lupus Damage-

October 24, 2002
“BONE AS A TARGET ORGAN FOR LUPUS DAMAGE”
WILL BE PRESENTED IN A SATELLITE SYMPOSIUM FOLLOWING
THE AMERICAN COLLEGE OF RHEUMATOLOGY ANNUAL MEETING

October 4, 2002
Genelabs Technologies to Present at UBS Warburg Global Life Sciences Conference

September 30, 2002
GENELABS TECHNOLOGIES PRESENTS ANTIFUNGAL AND ANTIBACTERIAL IN VIVO EFFICACY DATA AT THE 42nd ANNUAL ICAAC CONFERENCE

September 19, 2002
GENELABS TECHNOLOGIES AND PATHEON ENTER INTO COMMERCIAL SUPPLY AGREEMENT FOR PRESTARA™

August 29, 2002
GENELABS RECEIVES APPROVABLE LETTER FROM FDA

August 14, 2002
GENELABS TECHNOLOGIES, INC. REPORTS SECOND QUARTER AND SIX MONTH 2002 FINANCIAL RESULTS

July 9, 2002
GENELABS TECHNOLOGIES COMPLETES OFFERING OF COMMON STOCK

June 20, 2002
GENELABS TECHNOLOGIES TO SEEK EUROPEAN APPROVAL OF ASLERA (TM) UNDER THE CENTRALIZED PROCEDURE

June 12, 2002
GENELABS TECHNOLOGIES PRESENTS ANTIFUNGAL RESEARCH AT THE 28TH NATIONAL MEDICINAL CHEMISTRY SYMPOSIUM

June 7, 2002
GENELABS TECHNOLOGIES TO PRESENT AT BIO 2002 INTERNATIONAL BIOTECHNOLOGY CONVENTION & EXHIBITION ON JUNE 11

May 29, 2002
GENELABS EXPECTS NEW FDA ACTION ON ASLERA (TM) NDA

May 13, 2002
GENELABS TECHNOLOGIES INC. REPORTS 2002 FIRST QUARTER FINANCIAL RESULTS

May 01, 2002
GENELABS TECHNOLOGIES AND THE UNIVERSITY OF IOWA RESEARCH FOUNDATION COLLABORATE ON HEPATITIS G VIRUS RESEARCH

April 01, 2002
GENELABS TECHNOLOGIES INC. REPORTS 2001 YEAR-END AND FOURTH QUARTER FINANCIAL RESULTS

February 14, 2002
GENELABS TECHNOLOGIES ANNOUNCES PUBLICATION OF NOVEL ANTIBACTERIAL COMPOUNDS

February 11, 2002
GENELABS TECHNOLOGIES ANNOUNCES PROMOTION OF DR. KENNETH E. SCHWARTZ

© Genelabs Technologies, Inc. All rights reserved. - Terms of Use